HIV/AIDS
Reports from Tohoku University describe recent advances in HIV/AIDS
Published in Hepatitis Weekly, August 18th, 2008
According to recent research from Sendai, Japan, "We report a case of a HIV and hepatitis B virus (HBV)-co-infected patient to whom entecavir (ETV) was administered initially before the notification regarding the potential mutagenesis effect on HIV against the nucleoside analog. Since initial evaluations indicated the advanced stage of chronic hepatitis B and preserved numbers of peripheral CD4+ lymphocytes without the manifestation of immunodeficiency, priority was given to the management of HBV."
"We started HBV therapy with ETV at a dose of 0.5 mg daily without using any HIV drugs. The viral loads of both HBV and HIV-1 decreased gradually during the 5 months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-08-18)
More Articles from Hepatitis Weekly
- Acute Hepatitis
New findings reported from S. Molina and co-authors describe advances in acute hepatitis - Cholangio Cancer
Scientists at University of Brescia detail research in cholangio cancer - Chronic Hepatitis
Studies from P. Pagliano and co-researchers yield new data on chronic hepatitis - Hepatitis
Researchers from University of Zurich report recent findings in hepatitis - Hepatitis B Virus
New hepatitis B virus study findings have been reported by N. Nurainy and co-researchers - Hepatitis B Virus
New hepatitis B virus study results reported from Ajou University, Medical Department - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
